ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,402.40
0.66%
S&P ASX All Technology
3,827.80
0.73%
Brent Oil
78.525
-0.88%
US Dollar vs AUD
1.59744
0.33%
Bitcoin
103,578.28
1.52%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Novartis Ag (0K9E) Share Price

Novartis Ag

Novartis Ag (0K9E)

LSE
76.79
0.00
( 0.00% )
Updated: 11:00:00
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
76.79
Bid
0.00
Offer
0.00
Volume
275
0.00 Day's Range 0.00
76.79 52 Week Range 76.79
Market Cap
156.961B
Previous Close
76.79
Open
-
Last Trade
149
@
8007.71
(O)
Last Trade Time
02:36:11
Financial Volume
-
VWAP
-
Average Volume (3m)
1,114
Shares Outstanding
2,044,034,000
Dividend Yield
-
PE Ratio
13.74
Earnings Per Share (EPS)
7.27
Revenue
54.11B
Net Profit
14.85B

About Novartis Ag

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.novartis.com
Headquarters
Basel, Che
Founded
-
Novartis Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0K9E. The last closing price for Novartis was US$76.79. Over the last year, Novartis shares have traded in a share price range of US$ 76.79 to US$ 76.79.

Novartis currently has 2,044,034,000 shares in issue. The market capitalisation of Novartis is US$156.96 billion. Novartis has a price to earnings ratio (PE ratio) of 13.74.

Ask ADVFN Intelligence (AI)

0K9E Latest News

More News

NOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expansion And Breakthrough Innovation Launching Five...

N -- Full year net sales for continuing operations1 up 9% (cc2, +6% USD): -- Pharmaceuticals BU growing 12% (cc) driven by Cosentyx USD 3.6 billion (+28% cc), Entresto USD 1.7 billion (+71% cc...

29 January 2020
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Erzielt 2019 Ein Starkes Umsatzwachstum, Margen-steigerungen Und Bahnbrechende Innovatione...

N -- Der Nettoumsatz der fortzuführenden Geschäftsbereiche1 steigt 2019 um 9% (kWk2, +6% USD): -- Die Geschäftseinheit Pharmaceuticals wächst um 12% (kWk), getragen von...

29 January 2020
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis A Réalisé En 2019 Une Forte Croissance De Son Chiffre D'affaires, Une Augmentation De Sa...

N -- Hausse du chiffre d'affaires net des activités poursuivies1 de 9% sur l'exercice entier (tcc2, +6% USD): -- Pharmaceuticals: cette unité opérationnelle progresse de...

29 January 2020
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Completes Tender Offer For All Outstanding Shares Of The Medicines Company

N Basel, January 6, 2020 -- Novartis AG (NYSE: NVS) ("Novartis") today announced the successful completion of the previously announced tender offer by its indirect wholly-owned...

06 January 2020
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Provides Update On Luster Phase Iii Studies In Patients With Uncontrolled Gina 4/5 Asthma

N -- Pooled analyses of LUSTER 1 and 2 did not support further development of Fevipiprant in asthma as a primary indication -- Fevipiprant was well tolerated with adverse events balanced across...

16 December 2019
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Tender Offer For The Medicines Company Commences

N Basel, December 5, 2019 -- Novartis AG (NYSE: NVS) ("Novartis") today announced that its indirect wholly-owned subsidiary, Medusa Merger Corporation, a Delaware corporation...

05 December 2019
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis To Acquire The Medicines Company For Usd 9.7 Bn, Adding Inclisiran, A Potentially Transfor...

N -- Over 50 million secondary prevention patients worldwide with atherosclerotic cardiovascular disease (ASCVD) or familial hypercholesterolemia (FH) on current standard of care do not achieve...

25 November 2019
UK Regulatory

NOVARTIS AG CHF0.50(REGD) New Novartis Medicine Adakveo(R) (crizanlizumab) Approved By Fda To Reduce Frequency Of Pain Crises...

N -- Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications1 -- Adakveo reduced the annual rate of sickle cell pain crises by 45% compared to...

16 November 2019
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Shows Encouraging Results Versus Humira(R)* From First-of-its-kind Head-to-hea...

N -- Cosentyx narrowly missed statistical significance for superiority in ACR 20, the primary endpoint of the EXCEED trial, while showing numerically higher results versus Humira(R)*[1]...

01 November 2019
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Announces Avxs-101 Intrathecal Study Update

N -- FDA placed a partial hold on AVXS-101 intrathecal clinical trials for SMA patients based on findings in a small pre-clinical animal study -- Adverse events that might be expected from the...

30 October 2019
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10076.7976.7976.7911476.79DE
40076.7976.7976.7937376.79DE
120076.7976.7976.79111476.79DE
260076.7976.7976.79178376.79DE
520076.7976.7976.79891576.79DE
1560076.7976.7976.792122876.79DE
2600076.7976.7976.791775676.79DE

0K9E - Frequently Asked Questions (FAQ)

What is the current Novartis share price?
The current share price of Novartis is US$ 76.79
How many Novartis shares are in issue?
Novartis has 2,044,034,000 shares in issue
What is the market cap of Novartis?
The market capitalisation of Novartis is USD 156.96B
What is the 1 year trading range for Novartis share price?
Novartis has traded in the range of US$ 76.79 to US$ 76.79 during the past year
What is the PE ratio of Novartis?
The price to earnings ratio of Novartis is 13.74
What is the cash to sales ratio of Novartis?
The cash to sales ratio of Novartis is 3.77
What is the reporting currency for Novartis?
Novartis reports financial results in USD
What is the latest annual turnover for Novartis?
The latest annual turnover of Novartis is USD 54.11B
What is the latest annual profit for Novartis?
The latest annual profit of Novartis is USD 14.85B
What is the registered address of Novartis?
The registered address for Novartis is PO BOX, BASEL, 4002
What is the Novartis website address?
The website address for Novartis is www.novartis.com
Which industry sector does Novartis operate in?
Novartis operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BSFABsf Enterprise Plc
3.50p
(40.00%)
13.75M
STBSecure Trust Bank Plc
458.00p
(31.61%)
758.14k
NTOGNostra Terra Oil And Gas Company Plc
0.039p
(23.81%)
454.14M
TIATialis Essential It Plc
26.50p
(23.26%)
104.56k
CBGClose Brothers Group Plc
299.60p
(22.39%)
3.88M
NTQEnteq Technologies Plc
1.25p
(-23.31%)
2.98M
QBTQuantum Blockchain Technologies Plc
1.525p
(-17.12%)
94.88M
QUIZQuiz Plc
0.65p
(-16.13%)
7.23M
DGIDg Innovate Plc
0.0215p
(-14.68%)
28.75M
RCGHRc365 Holding Plc
1.80p
(-14.29%)
1.7M
NTVONativo Resources Plc
0.0021p
(0.00%)
2.49B
PREMPremier African Minerals Limited
0.026p
(-3.70%)
602.46M
NTOGNostra Terra Oil And Gas Company Plc
0.039p
(23.81%)
454.14M
TRPTower Resources Plc
0.0305p
(0.00%)
421.62M
SYMESupply@me Capital Plc
0.0029p
(-6.45%)
418.04M

Discussion

View Full Feed
uksausage uksausage 2 minutes ago
exactly

for now they need to focus on Natural gas energy production for data centers and the like (behind the meter).

Nuclear only comes in when you look at hydrogen production which is lower priority for the nation and also still not commercially available from FCEL (S
FCEL
Trooperstocks Trooperstocks 2 minutes ago
SGTM’s sustainable product lines will significantly amplify the company’s reach, providing a valuable platform to promote current and future offerings.
SGTM
Hosai Hosai 2 minutes ago
Much better to have a smaller, successful phase 2b/3 in the endpoints EMA care most about, in which due to being smaller it's harder to have low p values than a 'proper' phase 3, that also has a fair amount of dropouts in the case of Donnanemab, that can in rare cases kill patients, causes ARIA, shr
AVXL
Chiron Chiron 2 minutes ago
Trump is back, regulations don't matter anymore. It's going to 10 - 15 cents in 2025
GVSI
learningcurve2020 learningcurve2020 2 minutes ago
“Management” are now in their 70’s and 80’s. The company began back in 1996 and has burned through hundreds and hundreds of millions of dollars on one lousy trial for one orphan indication. Whatever business model they’re following hasn’t been described to investors in thirty years!
NWBO
iwitness4jc iwitness4jc 3 minutes ago
Looks like there is a pretty good possibility of an r/s if the uplist price fails to grow.

If the management decided that is the right time to jump into Nasdaq, and we have not achieved yet the organic price will be when the management will decide to expedite the uplisting process thr
IQST
prototype_101 prototype_101 3 minutes ago
Trump in, Hindenburg out: US short-seller firm shuts down
https://www.msn.com/en-in/news/world/trump-in-hindenburg-out-us-short-seller-firm-shuts-down-3-days-before-us-president-elects-swearing-in/ar-AA1xjbxr?ocid=BingNewsVerp

20 MILLION Shorts Covering Deadline Established Jun
LWLG
al44 al44 3 minutes ago
Restore the rule of law: pardon them all

By Mike McDaniel


It's time for the lies and coverups to stop. The process of ending the two-tiered, D/s/c system of injustice begins with the inauguration of Donald Trump. Step two is unconditional pardons for everyone in
ThePieMan ThePieMan 3 minutes ago
Wow, picked up more after drop. Blue skies ahead. Looks like a battle to try and crush this tiny upstart company from taking on the big boys this morning. Someone doesn't like all these great results coming from these "unknowns" after billions wasted on other forms of AI
VRSSF
Bionic Man Bionic Man 3 minutes ago
Picked up 15 thousand at .99. I'll buy more on the dips.
LITM
Investor2014 Investor2014 3 minutes ago
I am ok with the P2b/3 trial as exploratory. The Anavex mistake was to not start, as they said they would, a confirmatory trial alongside exploring approval paths with the P2b/3 data.
AVXL
Denzel-72 Denzel-72 3 minutes ago
OTC IS DEAD ☠️  
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 24px"It's over for poor people trying to get ahead 
VGLS
IcyGalaxy60 IcyGalaxy60 3 minutes ago
Who are they buying mt. vernon from?
NBRI
microcapbiotech microcapbiotech 4 minutes ago
No, I don't think they will cut back on grants. In the big picture, the amounts are miniscule to them and they are needed if they want smaller biotech's to have a shot at producing needed therapies.
MRKR
Chiron Chiron 4 minutes ago
This garbage is done. 
ASII
Denzel-72 Denzel-72 4 minutes ago
OTC IS DEAD ☠️  
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 24px"It's over for poor people trying to get ahead 
KEGS
Joe99999! Joe99999! 4 minutes ago
Volume is looking good lately. Lots of buys.!!
IQST
RIGATONI RIGATONI 4 minutes ago
$2.00 break in the works ~Rig
igotthemojo igotthemojo 4 minutes ago
Drill baby drill also involves natural gas…trump loves natural gas…and natural gas and fuel cells are a match made in heaven…so is nuclear and fuel cells…

But fcel kept hyping themselves as a hydrogen company…and now that hydrogen is out for the next 4 yrs, they are suffering the con
FCEL
uksausage uksausage 4 minutes ago
Listen to the calls after Girsky was appointed CEO. not from 3 years ago.
He and Mary have the experience of major vehicle manufacturing and understanding of what national accounts need and their processes.
His interview describing his first 100 days - day one was the fires in BEVS lea
FCEL
haha11 haha11 4 minutes ago
$DRIP...(BEAR 2X)..30.... DLY...Trend HH .. .

30.
https://schrts.co/DHVAruQJ
DLY.
https://schrts.co/kqbueNMf
DRIP
stpetesal stpetesal 5 minutes ago
I picked a little as well and in for the long term.
TCNNF
squidink squidink 5 minutes ago
Show us proof bud!
AABB
jobynimble jobynimble 5 minutes ago
I get it, so am I… 🥶

Your Recent History

LSE
0K9E
Novartis
BIT
NSCIT2125309
African Development Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads